EML4-ALK kinase inhibitor 1
EML4-ALK kinase inhibitor 1 is a potent, orally bioavailable small molecule that selectively targets the EML4-ALK fusion oncoprotein with an IC50 of 1 nM. It is widely used in preclinical research to investigate ALK-driven non-small cell lung cancer (NSCLC) in both cellular assays and animal models.
Product Specifications
CAS Number
1373409-08-5
Product Name Alternative
EML4 ALK kinase inhibitor 1, EML4-ALK kinase inhibitor 1, EML4-ALK, EML4-ALK kinase inhibitor 1
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.14% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.61 mM) ; DMSO:99 mg/mL (170.47 mM)
Smiles
CCc1nc (C (N) =O) c (Nc2ccc (N3CCC (CC3) N3CCN (C) CC3) c (OC) c2) nc1N[C@H]1CC[C@@H] (CC1) OC
Molecular Formula
C31H48N8O3
Molecular Weight
580.76
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog